Antimycobacterial pyrroles: Synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 6, 2000, Pages 1423-1432

  Ragno, Rino ^a   Marshall, Garland R ^a   Di Santo, Roberto ^b   Costi, Roberta ^b   Massa, Silvio ^c   Rompei, Raffaello ^d   Artico, Marino ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Cattedra di Microbiologia Applicata   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; PYRROLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; PYRROLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SPECTROPHOTOMETRY, INFRARED; VERO CELLS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0034131292     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00061-4     Document Type: Article

References (37)

1. Baker R.W., Mitscher L.A., Arain T.M., Shawar R., Stover C.K. Ann. Rep. Med. Chem. 31:1996;161.
2. Duncan K. Exp. Opin. Ther. Patents. 7:1997;129.
3. Niccolai, D.; Tarsi, L.; Thomas, R. J. Chem. Commun. 1997, 2333.
4. Horsburgh C.R. Jr. The New England Journal of Medicine. 324:1991;1332.
5. Heifets L. Antimicrob. Agents Chemother. 40:1996;1759.
6. Barbachyn M.R., Hutchinson D.K., Brickner S.J., Cynamom M.H., Kilburn J.O., Klemens S.P., Glickman S.E., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., Zurenke G.E. J. Med. Chem. 39:1996;680.
7. Ashtekar D.R., Costa-Pereira R., Shrinivasan T., Iyyer R., Vishvanathan N., Rittel W. Diagn. Microbiol. Infect. Dis. 14:1991;465.
8. Nagarajan K., Shankar R.G., Rajappa S., Shenopy S.J., Costa-Pereira R. Eur. J. Med. Chem. 24:1989;631.
9. Ashtekar D.R., Costa-Pereira R., Nagarajan K., Vishvanathan N., Bhatt A.D., Rittel W. Antimicrob. Agents Chemother. 37:1993;183.
10. Cynamon M.H., Gimi R., Gyenes F., Sharpe C.A., Bergmann K.E., Han H.J., Gregor L.B., Rapolu R., Luciano G., Welch J.T. J. Med. Chem. 38:1995;3902.
11. Cynamon M.H., Speirs R.J., Welch J.T. Antimicrob. Agents Chemother. 42:1998;462.
12. Johnsson K., Schultz P.G. J. Am. Chem. Soc. 116:1994;7425.
13. Dessen A., Quemard A., Blanchard J.S., Jacobs W.R. Jr., Sacchettini J.C. Science. 24:1995;1638.
14. Deidda D., Lampis G., Fioravanti R., Biava M., Porretta G.C., Zanetti S., Pompei R. Antimicrob. Agents Chemother. 42:1998;3035.
15. Di Santo R., Costi R., Artico M., Massa S., Lampis G., Deidda D., Pompei R. Bioorg. Med. Chem. Lett. 8:1998;2931.
16. Massa S., Di Santo R., Mai A., Botta M., Artico M., Panico S., Simonetti G. Farmaco. 45:1990;833.
17. Massa S., Di Santo R., Costi R., Mai A., Artico M., Retico A., Apuzzo G., Artico M., Simonetti G. Med. Chem. Research. 3:1993;192.
18. Massa S., Di Santo R., Artico M., Costi R., Di Filippo C., Simonetti G., Retico A., Artico M. Eur. Bull. Drug Research. 1:1992;12.
19. Cramer R.D.III, Patterson D., Bunce J. J. Am. Chem. Soc. 110:1988;5959.
20. Cramer, R. D., III; DePriest, S.; Patterson, D.; Hecht, P. In 3-D-QSAR in Drug Design; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 443-485.
21. Cramer, R. D., III; Wold, S. B. US Patent 5,025,388, 18 June 1991.
22. Hallinan E.A., Hagen T.J., Husa R.K., Tsymbalov S., Rao S.N., van Hoeck J.-P., Rafferty M.F., Stapelfeld A., Savage M.A., Reichman M. J. Med. Chem. 36:1993;3293.
23. van Leusen, A. M.; Bouma, R. J.; Possel, O. Tetrahedron Lett. 1975, 3487.
24. Greco G., Novellino E., Fiorini I., Nacci V., Campiani G., Ciani S.M., Garofalo A., Bernasconi P., Mennini T. J. Med. Chem. 37:1994;4100.
25. Tafi A., Anastassopoulous J., Theophanides T., Botta M., Corelli F., Massa S., Artico M., Costi R., Di Santo R., Ragno R. J. Med. Chem. 39:1996;1227.
26. In Tripos Associates, Inc., 1699 S Hanley Rd, St. Louis, MO 63144, USA.
27. Halgren T.A. Journal of Computational Chemistry. 17:1996;490.
28. Lindgren F., Geladi P., Rannar S., Wold S. J. Chemometrics. 8:1994;349.
29. Clark M., Cramer R.I. Quant. Struct. Act. Relat. 12:1993;137.
30. In Kellogg, K. E.; Abraham, D. J.; Richmond, VA 23298-0540.
31. Kellog G., Semus S., Abraham D. HINT: J. Comput. Aided Mol. Design. 5:1991;545.
32. Cramer C.J. Acc. Chem. Res. 26:1993;599.
33. Hawkins, J. E.; Wallace, R. J.; Brown, B. A. In Manual of Clinical Microbiology; Balows, W. J.; Hausler, K. L.; Hermann, K. L.; Isemberg, H. D.; Shadomy, H. J., Eds. ASM: Washington, DC, 1991; pp 1138-1152.
34. National Committee for Clinical Laboratory Standards. Antimycobacterial Susceptibility Testing. Proposed Standard M24; NCCLS: Villanova, PA, 1990.
35. Brown, B. A.; Swenson, J. M.; Wallace, R. J., Jr. In Clinical Microbiology Procedures Handbook American Society for Microbiology: Washington, DC, 1992; Vol. I.
36. Helfets L. Antimicrob. Agents Chemother. 40:1996;1759.
37. Inderlied, C. B.; Salenger, M. In Manual of Clinical Microbiology, 5th ed.; Murray, P. R.; Baron, E. J.; Pfaller, M. A.; Tenover, F. C.; Volken, R. H., Eds.; American Society of Microbiology: Washington, DC; pp 1385-1404.